STERIS plc reported revenue of $1.49B for the period ended 2026-06-30, +7.3% year on year. Net income was $0.20B, a 13.4% net margin on a 45.8% gross margin. The largest revenue line is Healthcare at 70% of the total. Free cash flow for the period was $0.28B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $1.49B | +7.3% |
| Gross profit | $0.68B | — |
| Operating income | $0.29B | — |
| Net income | $0.20B | +12.8% |
| Gross margin | 45.8% | Net margin 13.4% |
| Segment | Revenue | Share |
|---|---|---|
| Healthcare | $1.05B | 70.2% |
| Applied Sterilization Technologies | $0.30B | 19.9% |
| Life Science | $0.15B | 9.8% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $0.81B | 54.2% |
| R&D | $0.03B | 1.9% |
| SG&A | $0.37B | 24.8% |
| Tax & other | $0.09B | 5.7% |
| Item | Amount |
|---|---|
| Total assets | $10.74B |
| Total liabilities | $3.51B |
| Shareholders' equity | $7.22B |
| Equity / assets | 67.3% |
| Operating cash flow | $0.37B |
| Capital expenditure | $0.09B |
| Free cash flow | $0.28B |
| Cash conversion (OCF / net income) | 183% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
SYK ・ SMCI ・ SYF ・ SNPS ・ SYY ・ TMUS ・ TROW ・ TTWO ・ TPR ・ TRGP ・ TGT ・ TEL
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies